<?xml version="1.0" encoding="UTF-8"?>
<fig id="pone.0199167.g001" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.pone.0199167.g001</object-id>
 <label>Fig 1</label>
 <caption>
  <title>Description of the cell-free 
   <italic>in vitro</italic> experimental system producing antiviral hypothiocyanite or hypoiodite.
  </title>
  <p>We established an 
   <italic>in vitro</italic> experimental system to study the antiviral action of the LPO/H
   <sub>2</sub>O
   <sub>2</sub>/(SCN
   <sup>-</sup>/I
   <sup>-</sup>) system in the absence of epithelial cells. H
   <sub>2</sub>O
   <sub>2</sub> is generated in the enzymatic reaction of GO turning D-glucose into D-gluconate. Produced H
   <sub>2</sub>O
   <sub>2</sub> is used by LPO to oxidize its potential substrates, SCN
   <sup>-</sup> or I
   <sup>-</sup>. The products of the enzymatic action of LPO are either OSCN
   <sup>-</sup> or OI
   <sup>-</sup>, depending on the substrate used. Both, OSCN
   <sup>-</sup> or OI
   <sup>-</sup> have virucidal effects on influenza viruses. Physiologically relevant concentrations of LPO (6.5 μg/ml), SCN
   <sup>-</sup> or I
   <sup>-</sup> (400 μM), glucose (5 mM) and glucose oxidase (0.01 U/ml) are used. SCN
   <sup>-</sup>, thiocyanate; OSCN
   <sup>-</sup>, hypothiocyanite; I
   <sup>-</sup>, iodide; OI
   <sup>-</sup>, hypoiodite; LPO, lactoperoxidase; GO, glucose oxidase.
  </p>
 </caption>
 <graphic xlink:href="pone.0199167.g001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
